Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

A gain of function variant in PIEZO1 (E756del) and sickle cell disease.

Rooks H, Brewin J, Gardner K, Chakravorty S, Menzel S, Hannemann A, Gibson J, Rees DC.

Haematologica. 2018 Sep 20. pii: haematol.2018.202697. doi: 10.3324/haematol.2018.202697. [Epub ahead of print] No abstract available.

2.

Direct access cancer testing in primary care: a systematic review of use and clinical outcomes.

Smith CF, Tompson AC, Jones N, Brewin J, Spencer EA, Bankhead CR, Hobbs FR, Nicholson BD.

Br J Gen Pract. 2018 Sep;68(674):e594-e603. doi: 10.3399/bjgp18X698561. Epub 2018 Aug 13.

PMID:
30104328
3.

Online Health Seeking Behaviours: What Information Is Sought by Women Experiencing Miscarriage?

Pang PC, Temple-Smith M, Bellhouse C, Trieu VH, Kiropoulos L, Williams H, Coomarasamy A, Brewin J, Bowles A, Bilardi J.

Stud Health Technol Inform. 2018;252:118-125.

PMID:
30040693
4.

Oxidative stress and phosphatidylserine exposure in red cells from patients with sickle cell anaemia.

Hannemann A, Rees DC, Brewin JN, Noe A, Low B, Gibson JS.

Br J Haematol. 2018 Aug;182(4):567-578. doi: 10.1111/bjh.15441. Epub 2018 Jun 25.

5.

Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarction.

Tewari S, Renney G, Brewin J, Gardner K, Kirkham F, Inusa B, Barrett JE, Menzel S, Thein SL, Ward M, Rees DC.

Haematologica. 2018 Jul;103(7):1136-1142. doi: 10.3324/haematol.2018.187815. Epub 2018 Mar 15.

6.

Primary amyloidosis of the bladder.

Ho A, Davies MC, Guran R, Brewin J.

Urol Case Rep. 2018 Jan 31;17:111-113. doi: 10.1016/j.eucr.2018.01.026. eCollection 2018 Mar. No abstract available.

7.

The effect of xanthine oxidase and hypoxanthine on the permeability of red cells from patients with sickle cell anemia.

Al Balushi HWM, Rees DC, Brewin JN, Hannemann A, Gibson JS.

Physiol Rep. 2018 Mar;6(5). doi: 10.14814/phy2.13626.

8.

A pragmatic group sequential, placebo-controlled, randomised trial to determine the effectiveness of glyceryl trinitrate for retained placenta (GOT-IT): a study protocol.

Denison FC, Norrie J, Lawton J, Norman JE, Scotland G, McPherson GC, McDonald A, Forrest M, Hudson J, Brewin J, Peace M, Clarkson C, Brook-Smith S, Morrow S, Hallowell N, Hodges L, Carruthers KF.

BMJ Open. 2017 Sep 18;7(9):e017134. doi: 10.1136/bmjopen-2017-017134.

9.

Priorities for research in miscarriage: a priority setting partnership between people affected by miscarriage and professionals following the James Lind Alliance methodology.

Prior M, Bagness C, Brewin J, Coomarasamy A, Easthope L, Hepworth-Jones B, Hinshaw K, O'Toole E, Orford J, Regan L, Raine-Fenning N, Shakespeare J, Small R, Thornton J, Metcalf L.

BMJ Open. 2017 Aug 23;7(8):e016571. doi: 10.1136/bmjopen-2017-016571.

10.

How I manage sickle cell patients with high transcranial doppler results.

Brewin J, Kaya B, Chakravorty S.

Br J Haematol. 2017 Nov;179(3):377-388. doi: 10.1111/bjh.14850. Epub 2017 Aug 2. Review.

PMID:
28771666
11.

The super sickling haemoglobin HbS-Oman: a study of red cell sickling, K+ permeability and associations with disease severity in patients heterozygous for HbA and HbS-Oman (HbA/S-Oman genotype).

Al Balushi HWM, Wali Y, Al Awadi M, Al-Subhi T, Rees DC, Brewin JN, Hannemann A, Gibson JS.

Br J Haematol. 2017 Oct;179(2):256-265. doi: 10.1111/bjh.14851. Epub 2017 Jul 12.

PMID:
28699687
12.

Research priorities for stillbirth: process overview and results from UK Stillbirth Priority Setting Partnership.

Heazell AE, Whitworth MK, Whitcombe J, Glover SW, Bevan C, Brewin J, Calderwood C, Canter A, Jessop F, Johnson G, Martin I, Metcalf L.

Ultrasound Obstet Gynecol. 2015 Dec;46(6):641-7. doi: 10.1002/uog.15738. No abstract available.

13.

Penile lesion in end-stage renal failure - cancer or otherwise?: Calcific uremic arteriolopathy presenting with a penile lesion.

Malthouse T, Lam W, Brewin J, Watkin N, Ayres B, Nitkunan T.

Can Urol Assoc J. 2015 Mar-Apr;9(3-4):136-7. doi: 10.5489/cuaj.2331.

14.

The Relationship Between Technical And Nontechnical Skills Within A Simulation-Based Ureteroscopy Training Environment.

Brunckhorst O, Shahid S, Aydin A, Khan S, McIlhenny C, Brewin J, Sahai A, Bello F, Kneebone R, Shamim Khan M, Dasgupta P, Ahmed K.

J Surg Educ. 2015 Sep-Oct;72(5):1039-44. doi: 10.1016/j.jsurg.2015.04.002. Epub 2015 May 14.

PMID:
25980828
15.

Simulation-based ureteroscopy skills training curriculum with integration of technical and non-technical skills: a randomised controlled trial.

Brunckhorst O, Shahid S, Aydin A, McIlhenny C, Khan S, Raza SJ, Sahai A, Brewin J, Bello F, Kneebone R, Khan MS, Dasgupta P, Ahmed K.

Surg Endosc. 2015 Sep;29(9):2728-35. doi: 10.1007/s00464-014-3996-6. Epub 2014 Dec 5.

PMID:
25475519
16.

DNMT3A: the DioNysian MonsTer of acute myeloid leukaemia.

O'Brien EC, Brewin J, Chevassut T.

Ther Adv Hematol. 2014 Dec;5(6):187-96. doi: 10.1177/2040620714554538. Review.

17.

Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells.

Ricciardelli I, Blundell MP, Brewin J, Thrasher A, Pule M, Amrolia PJ.

Blood. 2014 Oct 16;124(16):2514-22. doi: 10.1182/blood-2014-01-553362. Epub 2014 Sep 2.

18.

Full immersion simulation: validation of a distributed simulation environment for technical and non-technical skills training in Urology.

Brewin J, Tang J, Dasgupta P, Khan MS, Ahmed K, Bello F, Kneebone R, Jaye P.

BJU Int. 2015 Jul;116(1):156-62. doi: 10.1111/bju.12875. Epub 2015 Mar 7.

19.

Face and content validation of the prostatic hyperplasia model and holmium laser surgery simulator.

Aydin A, Ahmed K, Brewin J, Khan MS, Dasgupta P, Aho T.

J Surg Educ. 2014 May-Jun;71(3):339-44. doi: 10.1016/j.jsurg.2013.11.004. Epub 2013 Dec 31.

PMID:
24797849
20.

Face, content, and construct validation of the Bristol TURP trainer.

Brewin J, Ahmed K, Khan MS, Jaye P, Dasgupta P.

J Surg Educ. 2014 Jul-Aug;71(4):500-5. doi: 10.1016/j.jsurg.2014.01.013. Epub 2014 Apr 13.

PMID:
24776866
21.

An update and review of simulation in urological training.

Brewin J, Ahmed K, Challacombe B.

Int J Surg. 2014;12(2):103-8. doi: 10.1016/j.ijsu.2013.11.012. Epub 2013 Dec 4. Review.

22.

Rapid generation of EBV-specific cytotoxic T lymphocytes resistant to calcineurin inhibitors for adoptive immunotherapy.

Ricciardelli I, Brewin J, Lugthart G, Albon SJ, Pule M, Amrolia PJ.

Am J Transplant. 2013 Dec;13(12):3244-52. doi: 10.1111/ajt.12475. Epub 2013 Oct 8.

23.

Genomic landscapes and clonality of de novo AML.

Brewin J, Horne G, Chevassut T.

N Engl J Med. 2013 Oct 10;369(15):1472-3. doi: 10.1056/NEJMc1308782. No abstract available.

PMID:
24106951
24.

DNMT3A mutations at R882 hotspot are only found in major clones of acute myeloid leukemia.

Bisling KE, Brewin JN, McGovern AP, Horne GA, Rider T, Stewart HJ, Ramsahoye BH, Chevassut TJ.

Leuk Lymphoma. 2014 Mar;55(3):711-4. doi: 10.3109/10428194.2013.811580. Epub 2013 Jul 25. No abstract available.

PMID:
23741974
25.

Optimization of methodology for production of CD25/CD71 allodepleted donor T cells for clinical use.

Albon SJ, Mancao C, Gilmour K, White G, Ricciardelli I, Brewin J, Lugthart G, Wallace R, Amrolia PJ.

Cytotherapy. 2013 Jan;15(1):109-21. doi: 10.1016/j.jcyt.2012.10.007.

PMID:
23260091
26.

Rapid detection of DNMT3A R882 codon mutations allows early identification of poor risk patients with acute myeloid leukemia.

Brewin JN, Horne GA, Bisling KE, Stewart HJ, Chevassut TJ.

Leuk Lymphoma. 2013 Jun;54(6):1336-9. doi: 10.3109/10428194.2012.736986. Epub 2012 Nov 1. No abstract available.

PMID:
23035745
27.

Genetic profiling in acute myeloid leukemia.

Horne G, Brewin J, Chevassut T.

N Engl J Med. 2012 Jun 14;366(24):2321; author reply 2321-2. doi: 10.1056/NEJMc1204662. No abstract available.

28.

Face, content and construct validation of the first virtual reality laparoscopic nephrectomy simulator.

Brewin J, Nedas T, Challacombe B, Elhage O, Keisu J, Dasgupta P.

BJU Int. 2010 Sep;106(6):850-4. doi: 10.1111/j.1464-410X.2009.09193.x. Epub 2010 Jan 29.

29.

The association between substance misuse and first-episode psychosis in a defined UK geographical area during the 1990s.

Donoghue K, Medley I, Brewin J, Glazebrook C, Mason P, Cantwell R, Jones PB, Harrison G, Doody GA.

Soc Psychiatry Psychiatr Epidemiol. 2011 Feb;46(2):137-42. doi: 10.1007/s00127-009-0175-5. Epub 2009 Dec 31.

PMID:
20043146
30.

Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy.

Samarasinghe S, Mancao C, Pule M, Nawroly N, Karlsson H, Brewin J, Openshaw P, Gaspar HB, Veys P, Amrolia PJ.

Blood. 2010 Jan 14;115(2):396-407. doi: 10.1182/blood-2009-08-235895. Epub 2009 Nov 4.

31.

Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease.

Brewin J, Mancao C, Straathof K, Karlsson H, Samarasinghe S, Amrolia PJ, Pule M.

Blood. 2009 Nov 26;114(23):4792-803. doi: 10.1182/blood-2009-07-228387. Epub 2009 Sep 21.

32.

The prevalence of cervical ribs in a London population.

Brewin J, Hill M, Ellis H.

Clin Anat. 2009 Apr;22(3):331-6. doi: 10.1002/ca.20774.

PMID:
19280652
33.

Is the incidence of psychotic disorder in decline? Epidemiological evidence from two decades of research.

Kirkbride JB, Croudace T, Brewin J, Donoghue K, Mason P, Glazebrook C, Medley I, Harrison G, Cooper JE, Doody GA, Jones PB.

Int J Epidemiol. 2009 Oct;38(5):1255-64. doi: 10.1093/ije/dyn168. Epub 2008 Aug 25. Erratum in: Int J Epidemiol. 2009 Dec;38(6):1753.

34.

Supracondylar periprosthetic femoral fractures following total knee arthroplasty: treatment with a retrograde intramedullary nail.

Chettiar K, Jackson MP, Brewin J, Dass D, Butler-Manuel PA.

Int Orthop. 2009 Aug;33(4):981-5. doi: 10.1007/s00264-008-0587-y. Epub 2008 Jun 6.

35.
36.

Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidone.

Martin SD, Libretto SE, Pratt DJ, Brewin JS, Huq ZU, Saleh BT.

Curr Med Res Opin. 2003;19(4):298-305.

PMID:
12841922
37.

Minor physical anomalies in schizophrenia: is age a confounding factor?

Lloyd T, Doody G, Brewin J, Park B, Jones P.

Schizophr Res. 2003 May 1;61(1):67-73.

PMID:
12648737
38.

Aggressive incidents in first-episode psychosis.

Milton J, Amin S, Singh SP, Harrison G, Jones P, Croudace T, Medley I, Brewin J.

Br J Psychiatry. 2001 May;178:433-40.

PMID:
11331559
39.

Diagnostic stability of first-episode psychosis. Comparison of ICD-10 and DSM-III-R systems.

Amin S, Singh SP, Brewin J, Jones PB, Medley I, Harrison G.

Br J Psychiatry. 1999 Dec;175:537-43.

PMID:
10789350
40.

Prevalence of substance misuse in first-episode psychosis.

Cantwell R, Brewin J, Glazebrook C, Dalkin T, Fox R, Medley I, Harrison G.

Br J Psychiatry. 1999 Feb;174:150-3.

PMID:
10211169
41.

Incidence of schizophrenia in Nottingham. A comparison of two cohorts, 1978-80 and 1992-94.

Brewin J, Cantwell R, Dalkin T, Fox R, Medley I, Glazebrook C, Kwiecinski R, Harrison G.

Br J Psychiatry. 1997 Aug;171:140-4.

PMID:
9337949
42.

Increased incidence of psychotic disorders in migrants from the Caribbean to the United Kingdom.

Harrison G, Glazebrook C, Brewin J, Cantwell R, Dalkin T, Fox R, Jones P, Medley I.

Psychol Med. 1997 Jul;27(4):799-806.

PMID:
9234458

Supplemental Content

Loading ...
Support Center